You are here: Industry Insights > SARS-Cov2

News List

Researchers Show How COVID-19 Virus Triggers Immune Signaling "Storm" prnewswire
May 17, 2021
Researchers have discovered new ways in which the COVID-19 virus causes human immune cells to overreact, a deadly part of the disease.
The drug aprotinin inhibits entry of SARS-CoV2 in host cells worldpharmanews
November 26, 2020
The surface of the SARS-CoV-2 virus is studded with spike proteins. The virus needs these in order to dock onto proteins (ACE2 receptors) on the surface of the host cell.
Sotira Finds Preliminary Success Developing Intranasal COVID-19 Vaccine Alternative americanpharmaceuticalreview
October 29, 2020
Sotira has announced preliminary findings of preclinical safety and efficacy studies for its patent-pending vaccine alternative that has shown in on-going preclinical testing to attenuate COVID-19 infection.
IncellDx to Study Maraviroc in COVID-19 Phase 2 Clinical Trial americanpharmaceuticalreview
October 26, 2020
IncellDx will collaborate on the SARS-CoV2 Clinical Trial NCT04435522 involving Pfizer's FDA-approved CCR5 antagonist Maraviroc.
Hackensack Meridian Health Enrolling Individuals for COVID-19 Vaccine Clinical Trial americanpharmaceuticalreview
August 31, 2020
Hackensack Meridian Health is now enrolling individuals in a COVID-19 vaccine clinical trial.
Computational methodologies can be effective in predicting and prioritising key targets related to COVID expresspharma
April 14, 2020
NovaLead Pharma, a Pune-based company has utilised its experience of drug repurposing has deployed computational technology to identify 42 existing drugs which may be potentially effective against the SARS-Cov2 virus.